ClinicalTrials.gg
Not yet recruitingNCT07937865Updated Nov 16, 2026

Early Intervention for Postpartum PTSD: Comparing Written Exposure and Capnometry-Guided Breathing Therapy - Phase 2

An interventional study of Written Exposure Therapy (WET) and Capnometry-Guided Breathing Intervention (CGRI) in Written Exposure Therapy, Breathing Techniques and PTSD (Childbirth-Related), sponsored by Stanford University. Not yet recruiting at 2 sites in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Stanford University · Not applicable, Interventional, and Treatment

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 31 studies in Stress Disorders, Post-Traumatic by Stanford University — 8 open to participants now, 9 under way, none of them phase 3. Stress Disorders, Post-Traumatic · Stanford University.

Planned enrollment
12th of 25
60 · median 42
Started
2027
the only one that year
No phase
19 of 31
7 open now
Registered
31st of 31
by date

Among the 31 studies in Stress Disorders, Post-Traumatic by Stanford University, this one is the 12th largest by planned enrollment of the 25 interventional ones that give a count, is the only one that started in 2027, is one of 19 with no phase, and was the 31st registered.

Stress Disorders, Post-Traumatic

2,687 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 603 are open to participants now.

Browse Stress Disorders, Post-Traumatic studies →

Open to participants now

8 of the 31 studies in Stress Disorders, Post-Traumatic by Stanford University are open now, in 2 countries. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Where they have run

Who these studies take

Of the 417 Stress Disorders, Post-Traumatic studies recruiting now, 187 (45%) set no upper age limit and 204 (49%) stop at 75 or younger; 63 take children under 18; 89 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 31 studies in Stress Disorders, Post-Traumatic by Stanford University, or all of them as a file.
02

Study summary

The purpose of this study is to evaluate the feasibility, acceptability, and preliminary effectiveness of two early interventions, Written Exposure Therapy (WET) and Capnometry-Guided Breathing Intervention (CGRI), for reducing post-traumatic stress disorder (PTSD) symptoms following childbirth, compared with usual care.

03

Conditions studied

  • Written Exposure Therapy
  • Breathing Techniques
  • PTSD (Childbirth-Related)
  • Postpartum Care
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥18
  • Delivered a live infant within 5 days
  • Severe maternal morbidity or infant admitted to NICU
  • PCL-5 ≥28
  • English-speaking
  • Able to consent and participate

Exclusion criteria

Exclusion Criteria:

  • Active psychosis or mania
  • Current suicidal crisis
  • Current suicidal intent or plan
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Postpartum Standard of Care

    Participants will follow their current standard of care.

  • Experimental
    Written Exposure Therapy (WET)

    Participants will complete 5 writing sessions. One 50-minute session will be held in the hospital before discharge, followed by four 50-minute sessions by secure video once a week. Sessions are delivered by a trained study therapist under licensed clinician supervision.

    Behavioral: Written Exposure Therapy (WET)

  • Experimental
    Capnometry-Guided Breathing Intervention (CGRI)

    Participants will complete one 45-minute in-hospital training session using the device, which includes a tablet and breathing sensor. They will then practice guided breathing at home twice daily for about 17 minutes each time for 4 weeks, with weekly phone check-ins from study staff.

    Device: Capnometry-Guided Breathing Intervention (CGRI)

Interventions

  • BehavioralWritten Exposure Therapy (WET)

    Participants will complete 5 writing sessions. One 50-minute session will be held in the hospital before discharge, followed by four 50-minute sessions by secure video once a week. Sessions are delivered by a trained study therapist under licensed clinician supervision.

  • DeviceCapnometry-Guided Breathing Intervention (CGRI)

    Participants will complete one 45-minute in-hospital training session using the device, which includes a tablet and breathing sensor. They will then practice guided breathing at home twice daily for about 17 minutes each time for 4 weeks, with weekly phone check-ins from study staff.

06

What researchers measure

Primary outcomes

  1. Percentage of participants initiating assigned treatment

    Proportion of participants who begin their assigned intervention (≥1 session for WET; completion of initial training for CGRI)

    Time frame: Baseline (up to 2 weeks)

  2. Percentage of participants completing Written Exposure Therapy (WET)

    Time frame: Baseline to Week 6

  3. Percentage adherence to Written Exposure Therapy (WET)

    Time frame: Baseline to Week 6

  4. Percentage of participants completing Capnometry Guided Respiratory Intervention (CGRI)

    Time frame: Baseline to Week 6

  5. Percentage adherence to Capnometry Guided Respiratory Intervention (CGRI)

    Time frame: Baseline to Week 6

  6. Participant Satisfaction Scale Score using Client Satisfaction Questionnaire (CSQ-8)

    Participant satisfaction measured using the CSQ-8 questionaire, an 8-item scale. (Scale score 8 - 32. Higher scores represent greater satisfaction with treatment.)

    Time frame: Week 5

  7. Treatment credibility using the Opinion About Treatment (OAT) form

    Participant perceptions of treatment credibility will be measured using the OAT form. (Scale score 3 - 27. Higher scores represent greater perceived credibility of the intervention.)

    Time frame: Week 5

Secondary outcomes

  1. Change from baseline in PTSD Checklist for DSM-5 (PCL-5) Scale Score

    Change in PTSD symptoms during past week measured by the PTSD Checklist for DSM-5 (PCL-5), a 20-item self-report measure. (Score range 0 - 80, higher scores indicating greater severity of PTSD symptoms.).

    Time frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 6, Week 12

  2. Change from baseline in Edinburgh Postnatal Depression Scale (EPDS) Scale Score

    Participants complete the EPDS questionnaire, a 10-item scale assessing postpartum depressive symptoms over the past 7 days. (Score range 0 - 30, higher scores represents greater symptom severity.)

    Time frame: Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 6, Week 12

  3. Change from baseline in Whole Person Health Index (WPHI) Scale Score

    Participants complete WHPI questionaire, a 9 item scale assessing global health and functioning. (Score range 9 - 81, higher scores represent better health).

    Time frame: Baseline, Week 3, Week 6, Week 12

  4. Change from baseline in Generalized Anxiety Disorder Questionaire (GAD-7)

    Participants complete the GAD-7, a 7-item scale assessing anxiety symptoms over 2 weeks. (Score range 0 - 21, higher scores represent greater anxiety severity.)

    Time frame: Baseline, Week 3, Week 6, Week 12

  5. Change from baseline in Maternal-infant bonding (MIBS) Scale Score

    Participants complete the MIBS questionaire, an 8 item measure of bonding difficulties over the past few weeks (Score range 0 - 24, higher scores represent greater bonding impairment).

    Time frame: Baseline, Week 3, Week 6, Week 12

  6. Change from baseline in STanford Obstetric Recovery checKlist (STORK) scale score

    Participants complete the STORK questionnaire, a 47-item scale assessing postpartum recovery over the past 7 days. (Score range 0 - 188, higher score represents a greater degree of recovery)

    Time frame: Baseline, Week 3, Week 6, Week 12

  7. Change from baseline in Breastfeeding Self-Efficacy Scale-Short Form (BFSES-SF)

    Participants complete the BFSES-SF, a 14-item measure of breastfeeding self-efficacy (Score range 14 - 70, higher scores indicate greater breastfeeding confidence.)

    Time frame: Baseline, Week 3, Week 6, Week 12

  8. Percentage of participants completing hair sample collection at Baseline and Week 6

    Participants have hair samples collected at baseline and at Week 6 post treatment.

    Time frame: Baseline, Week 6

  9. Change in hair cortisol concentration between Baseline and Week 6

    Participants have hair samples collected at baseline and at Week 6 post treatment. Hair steroid concentrations reflect average systemic hormone exposure over the preceding weeks. Change in hair cortisol concentration from Baseline to Week 6

    Time frame: Baseline, Week 6

  10. Change in hair cortisone concentration between Baseline and Week 6

    Participants have hair samples collected at baseline and at Week 6 post treatment. Hair steroid concentrations reflect average systemic hormone exposure over the preceding weeks. Change in hair cortisone concentration from Baseline to Week 6

    Time frame: Baseline, Week 6

  11. Change in hair testosterone concentration between Baseline and Week 6

    Participants have hair samples collected at baseline and at Week 6 post treatment. Hair steroid concentrations reflect average systemic hormone exposure over the preceding weeks. Change in hair testosterone concentration from Baseline to Week 6

    Time frame: Baseline, Week 6

  12. Change in hair progesterone concentration between Baseline and Week 6

    Participants have hair samples collected at baseline and at Week 6 post treatment. Hair steroid concentrations reflect average systemic hormone exposure over the preceding weeks. Change in hair progesterone concentration from Baseline to Week 6

    Time frame: Baseline, Week 6

  13. Change in hair corticosterone concentration between Baseline and Week 6

    Participants have hair samples collected at baseline and at Week 6 post treatment. Hair steroid concentrations reflect average systemic hormone exposure over the preceding weeks. Change in hair corticosterone concentration from Baseline to Week 6

    Time frame: Baseline, Week 6

  14. Change in hair dehydroepiandrosterone (DHEA) concentration between Baseline and Week 6

    Participants have hair samples collected at baseline and at Week 6 post treatment. Hair steroid concentrations reflect average systemic hormone exposure over the preceding weeks. Change in hair dehydroepiandrosterone (DHEA) concentration values from Baseline to Week 6

    Time frame: Baseline, Week 6

  15. Change in hair androstenedione concentration between Baseline and Week 6

    Participants have hair samples collected at baseline and at Week 6 post treatment. Hair steroid concentrations reflect average systemic hormone exposure over the preceding weeks. Change in hair androstenedione concentration from Baseline to Week 6

    Time frame: Baseline, Week 6

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).

Supporting information: Study protocol

Time frame: Beginning 9 months and ending 36 months following article publication.

Access criteria: Wish whom? Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose. For what types of analysis? For individual participant data meta-analysis By what mechanism will data be made available? Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata. Information regarding submitting proposals and accessing data may be found at (Link to be provided).

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2027; primary completion for Jan 2028, 11 months later.

Of 1,065 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 11 months is below that.

Counting every sponsor, half of 1,093 studies reached it within 34 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 16, 2026
StartEst.
Feb 2027
Primary completionEst.
Jan 2028
CompletionEst.
Feb 2028
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07937865
Responsible party
Pervez Sultan (Professor of Anesthesiology, Perioperative and Pain Medicine (Obstetrics), Stanford University) — Principal investigator
First posted
Nov 16, 2026
Start date
Feb 2027 (estimated)
Primary completion
Jan 2028 (estimated)
Completion
Feb 2028 (estimated)
Last update
Nov 16, 2026

Study contacts

Pervez Sultan
principal investigator · Stanford University
Debra Kaysen
principal investigator · Stanford University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion